This document provides an annual refresher training on bloodborne pathogens. It reviews national and local disease numbers from 2010-2012, including cases of AIDS, hepatitis, tuberculosis, influenza and more. It discusses concepts of infection control and specific diseases like MRSA, HIV, hepatitis B and C, and influenza. It emphasizes prevention through immunizations, hygiene practices like handwashing, and cleaning/disinfection of surfaces and equipment to reduce disease transmission risks.
- COVID-19 generally causes mild disease in children, but a small proportion can develop severe disease requiring ICU care.
- Symptoms in children are usually fever, cough, sore throat and some may experience diarrhea or vomiting.
- Investigations show lymphopenia and elevated inflammatory markers. Chest imaging may show patchy infiltrates or ground glass opacities.
- Management involves isolation and supportive care. Severe cases are treated in hospitals. Most children recover well but underlying conditions increase risk of severe disease.
This document provides an overview of viral hepatitis, focusing on hepatitis A, B, C, D, and E. It discusses the taxonomy, transmission routes, clinical features, diagnosis, treatment, and prevention of each type of viral hepatitis. For hepatitis A, it summarizes the agent, host factors, environmental factors, clinical picture, laboratory diagnosis, treatment/management, and prevention including vaccines. For hepatitis B, it discusses global epidemiology, the structure and life cycle of HBV, transmission routes, the antigen-antibody response, interpretation of immunology tests, chronic infection treatment options, and vaccination schedules and programs. It also briefly summarizes hepatitis C, noting its milder clinical course but potential for chronic infection and liver
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)Dr Padmesh Vadakepat
This document provides a review and recommendations on the diagnosis and management of dengue in children. It discusses that dengue is endemic in many parts of Asia and the Americas. The virus is transmitted by mosquitoes Aedes aegypti and Aedes albopictus. Dengue classification has changed from dengue fever and dengue hemorrhagic fever to simply dengue, dengue with warning signs, and severe dengue. Diagnosis involves tests for the NS1 antigen, IgG and IgM antibodies. Treatment depends on severity and can involve outpatient, inpatient or emergency care, monitoring for shock and hemorrhage.
The document discusses COVID-19 in children. It notes that fewer cases have been reported in children than adults, with children representing about 14% of total cases. As of May 2021, over 3.9 million children in the US had tested positive. Most cases in children are mild and treatment consists of supportive care. The virus is transmitted through respiratory droplets and contact or surfaces. Family clustering appears to play a role in transmission between children. Symptoms in children tend to be mild and include cough, fever, and pharyngeal erythema.
Unite against COVID-19, Considerations in Childrenzaza2089
This document provides information on considerations for COVID-19 in children. It discusses COVID-19 facts such as transmission and signs/symptoms. Children of all ages can be infected, though cases are usually less severe than adults. Hospitalization is most common for those under 1 year old or with underlying conditions. Risk factors, diagnosis, management for outpatient and inpatient cases, prevention methods, and psychological support are also outlined.
This document provides information on COVID-19 in children, including its symptoms, risk factors for severe disease, complications, management, and similarities to Kawasaki disease. It discusses the typical clinical manifestations in children such as fever, cough, gastrointestinal symptoms, and dermatological findings. Risk factors for severe COVID-19 include underlying medical conditions and higher viral loads. Imaging may show ground glass opacities while labs can show elevated inflammatory markers and lymphopenia. Management involves supportive care, antibiotics for secondary infections, and Kawasaki disease treatments for overlapping cases.
“You can download this product from SlideTeam.net”
Spread awareness about the pandemic using the impressive visuals of our Corona Virus Disease 19 Powerpoint Presentation Slides. The easy-to-follow content of coronavirus PPT theme assists you to convey information to the audience of all ages, shapes, and sizes. This COVID 19 PowerPoint slideshow will help you explain the age risk factors, symptoms, and prevention methods concisely. Impactful data visualization tools like infographics in this novel coronavirus pneumonia PPT template enables you to effortlessly demonstrate sophisticated data. Compare the spread, incubation rate of coronavirus against other pandemics, and portray mortality rate through this corona PowerPoint presentation. Present crucial information like how long the virus lasts on different surfaces, and risk factors through this COVID PPT slideshow. Our 2019-nCoV acute respiratory disease PowerPoint theme helps you to illustrate the outbreak of the pandemic continent-wise. Download severe pneumonia with novel pathogens PPT template to explain crucial information related to the pandemic like effects on the stock market. https://bit.ly/3IN6j4F
- COVID-19 generally causes mild disease in children, but a small proportion can develop severe disease requiring ICU care.
- Symptoms in children are usually fever, cough, sore throat and some may experience diarrhea or vomiting.
- Investigations show lymphopenia and elevated inflammatory markers. Chest imaging may show patchy infiltrates or ground glass opacities.
- Management involves isolation and supportive care. Severe cases are treated in hospitals. Most children recover well but underlying conditions increase risk of severe disease.
This document provides an overview of viral hepatitis, focusing on hepatitis A, B, C, D, and E. It discusses the taxonomy, transmission routes, clinical features, diagnosis, treatment, and prevention of each type of viral hepatitis. For hepatitis A, it summarizes the agent, host factors, environmental factors, clinical picture, laboratory diagnosis, treatment/management, and prevention including vaccines. For hepatitis B, it discusses global epidemiology, the structure and life cycle of HBV, transmission routes, the antigen-antibody response, interpretation of immunology tests, chronic infection treatment options, and vaccination schedules and programs. It also briefly summarizes hepatitis C, noting its milder clinical course but potential for chronic infection and liver
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)Dr Padmesh Vadakepat
This document provides a review and recommendations on the diagnosis and management of dengue in children. It discusses that dengue is endemic in many parts of Asia and the Americas. The virus is transmitted by mosquitoes Aedes aegypti and Aedes albopictus. Dengue classification has changed from dengue fever and dengue hemorrhagic fever to simply dengue, dengue with warning signs, and severe dengue. Diagnosis involves tests for the NS1 antigen, IgG and IgM antibodies. Treatment depends on severity and can involve outpatient, inpatient or emergency care, monitoring for shock and hemorrhage.
The document discusses COVID-19 in children. It notes that fewer cases have been reported in children than adults, with children representing about 14% of total cases. As of May 2021, over 3.9 million children in the US had tested positive. Most cases in children are mild and treatment consists of supportive care. The virus is transmitted through respiratory droplets and contact or surfaces. Family clustering appears to play a role in transmission between children. Symptoms in children tend to be mild and include cough, fever, and pharyngeal erythema.
Unite against COVID-19, Considerations in Childrenzaza2089
This document provides information on considerations for COVID-19 in children. It discusses COVID-19 facts such as transmission and signs/symptoms. Children of all ages can be infected, though cases are usually less severe than adults. Hospitalization is most common for those under 1 year old or with underlying conditions. Risk factors, diagnosis, management for outpatient and inpatient cases, prevention methods, and psychological support are also outlined.
This document provides information on COVID-19 in children, including its symptoms, risk factors for severe disease, complications, management, and similarities to Kawasaki disease. It discusses the typical clinical manifestations in children such as fever, cough, gastrointestinal symptoms, and dermatological findings. Risk factors for severe COVID-19 include underlying medical conditions and higher viral loads. Imaging may show ground glass opacities while labs can show elevated inflammatory markers and lymphopenia. Management involves supportive care, antibiotics for secondary infections, and Kawasaki disease treatments for overlapping cases.
“You can download this product from SlideTeam.net”
Spread awareness about the pandemic using the impressive visuals of our Corona Virus Disease 19 Powerpoint Presentation Slides. The easy-to-follow content of coronavirus PPT theme assists you to convey information to the audience of all ages, shapes, and sizes. This COVID 19 PowerPoint slideshow will help you explain the age risk factors, symptoms, and prevention methods concisely. Impactful data visualization tools like infographics in this novel coronavirus pneumonia PPT template enables you to effortlessly demonstrate sophisticated data. Compare the spread, incubation rate of coronavirus against other pandemics, and portray mortality rate through this corona PowerPoint presentation. Present crucial information like how long the virus lasts on different surfaces, and risk factors through this COVID PPT slideshow. Our 2019-nCoV acute respiratory disease PowerPoint theme helps you to illustrate the outbreak of the pandemic continent-wise. Download severe pneumonia with novel pathogens PPT template to explain crucial information related to the pandemic like effects on the stock market. https://bit.ly/3IN6j4F
This document provides an overview of tuberculosis (TB). It discusses that TB infects around 9 million people and causes 1.5 million deaths annually, making it a major global health problem. Key topics covered include the causative agent Mycobacterium tuberculosis; epidemiology of TB including increasing rates of drug-resistant and HIV-associated TB; risk factors; clinical presentation; diagnosis using smear microscopy, culture, radiography and other tests; treatment of drug-sensitive and drug-resistant TB; prevention through contact investigation and vaccination; and challenges to eliminating TB. The presentation emphasizes the continued burden of TB worldwide despite available diagnostic tools and treatments.
This document discusses COVID-19 in children. It provides details on SARS-CoV-2, including its infectivity, replication sites, and stability on surfaces. It also summarizes the pathophysiology of COVID-19 in children, noting their lower morbidity is likely due to factors like lower ACE2 expression. The diagnosis section outlines common manifestations in children and molecular testing methods, sample collection, hematologic parameters, and poor prognostic markers seen in adults.
Clinical and epidemiological features of Children with COVID 19Ramin Nazari M.D
- Children can be infected with COVID-19 but symptoms tend to be mild. Severe cases have occurred but are rare, especially in otherwise healthy children. Younger children, especially infants, may be more vulnerable to severe illness.
- A study in China found that 34% of COVID-19 cases in children were confirmed via lab tests while 66% were suspected cases. The majority of cases were mild. Severe or critical cases were more common in younger age groups, especially children under 1 year old.
- While children can spread the virus, severity of illness in children is generally milder than in adults. No significant differences in infection rates between boys and girls were observed.
The document discusses the 2009 H1N1 influenza pandemic. It provides details on the virus, symptoms, transmission, management and treatment recommendations, and control measures. As of December 2009, over 9,500 deaths had been reported worldwide from the H1N1 virus. While the overall global mortality rate was approximately 1%, continued virus transmission was observed across many regions. Vaccines and antiviral medications such as oseltamivir were the primary interventions recommended for treatment and prevention.
Rekha Dehariya (M.Sc nursing 1st year) Bhopal Nursing College, Bhopal
Covid -19 has effected broud number of people all over the world. the health education is necessary to aware people about it.
1. In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China, causing a pneumonia outbreak of unknown origin.
2. The virus spread rapidly worldwide, and in March 2020 the WHO declared a global pandemic with over 118,000 cases across 114 countries.
3. Common symptoms of COVID-19, the disease caused by SARS-CoV-2, include fever, cough, and shortness of breath, with severe cases potentially resulting in acute respiratory distress.
Hepatitis A and typhoid fever are vaccine-preventable waterborne diseases transmitted through the fecal-oral route. They remain a major public health issue in Pakistan, with over two-thirds of the population lacking access to clean drinking water. Typhoid fever in particular is endemic in Pakistan, with high rates of multidrug-resistant Salmonella strains emerging. Vaccination is critical to control these diseases and reduce their significant health and economic burden.
The document profiles dengue infection in pregnancy at Sanglah Hospital in Bali, Indonesia. It finds that the highest percentage of infected women were in their third trimester (78%). Most women tested positive for dengue IgG antibodies (90.2%), indicating a secondary infection. Adverse outcomes for mothers included dengue-related death (14.6%) and preterm labor (17.1%). Few infants exhibited complications, with no neonatal deaths reported. The study provides insights into dengue infection patterns and effects during pregnancy in Bali.
Dengue Chikukunya & Malaria in the viewpoint of Medicine Paediatric & ObstetricsMuhammad Helmi
Multidisciplinary Seminar on Vector Borne Diseases such as dengue, malaria and chikungunya was discussed. It was introduced that vectors are living organisms that can transmit infectious diseases between humans or from animals to humans. There are two main types of vectors - biological and mechanical. Vector borne diseases account for over 17% of all infectious diseases and cause more than 1 billion cases and over 1 million deaths every year. Dengue, malaria and chikungunya were some of the key vector borne diseases highlighted. Their causative agents, transmission, clinical features and management were explored. Emphasis was placed on prevention and control of their vectors to curb the spread of these diseases.
Epidemiology of tb with recent advances acknowledged by whoRama shankar
This document provides an overview of tuberculosis epidemiology and recent advances in tuberculosis programs. It discusses the global and national burden of tuberculosis, the evolution of tuberculosis control programs in India including the National Tuberculosis Control Programme and Revised National Tuberculosis Control Programme. It covers diagnosis, treatment, drug-resistant tuberculosis, tuberculosis and HIV coinfection, and recent advances acknowledged by the WHO. The post-2015 tuberculosis strategy in relation to sustainable development goals is also mentioned.
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3gGPcTC
This document summarizes information from Dr. Tahseen J. Siddiqui on COVID-19. It discusses the three known coronaviruses that cause SARS, MERS, and COVID-19. It emphasizes that mitigation through strict social isolation is the best current strategy to slow transmission rates and prevent healthcare systems from being overwhelmed. The risks of personal infection are low but systemic risks are high if many require critical care simultaneously. Early action through testing, contact tracing, and quarantines have helped countries like Taiwan better control the spread.
Covid 19 aka mers cov2 update and perinatal covidSri ChowdarRy
This document provides an overview of COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2. It discusses the virology, epidemiology, clinical features, course, complications, diagnosis, and prevention of COVID-19. Key points include that SARS-CoV-2 is a betacoronavirus that uses the ACE2 receptor for cell entry, most infections are mild but some can be severe or critical, common symptoms include fever and cough but some patients are asymptomatic, and chest CT often shows bilateral ground-glass opacities consistent with viral pneumonia.
This document provides guidance on evaluating and managing acute febrile illness in returning travelers. It outlines:
1) Common causes of fever in returning travelers, including malaria, dengue, influenza, and enteric fever.
2) Recommendations for obtaining a thorough travel history, physical exam, and diagnostic testing based on the patient's symptoms, risk factors, and travel destinations.
3) Treatment guidelines for various infections based on disease severity and suspected pathogen.
This document provides information on updated disease notification responsibilities and immunization guidelines. It lists diseases that medical facilities must notify responders about after exposure. These include bloodborne, airborne, and droplet transmitted diseases like hepatitis, HIV, influenza, meningitis and more. The document discusses prevention of diseases through travel screening, herd immunity from vaccination, and recent disease case numbers. It provides guidance on healthcare worker vaccination and testing requirements.
This document provides an overview of emerging and re-emerging infectious diseases as well as potential agents of bioterrorism that could be encountered in an emergency department setting. It discusses several specific diseases including SARS, West Nile virus, influenza, anthrax, smallpox, and plague. For each disease, it summarizes the causative agent, transmission, signs and symptoms, diagnosis, and treatment. The overall goal is to introduce emergency physicians to these threats and how to recognize and respond to cases of emerging infection or potential bioterrorism.
Dengue is a mosquito-borne viral disease that is widespread in tropical and subtropical regions. It affects nearly 100 million people annually. The disease is caused by the dengue virus, which has four serotypes. It is transmitted by the bite of infected Aedes mosquitoes. There is no vaccine available to prevent dengue. Treatment involves fluid replacement and pain management. Prevention focuses on reducing mosquito habitats and biting through the use of insect repellents, bed nets, and larviciding.
This document discusses sexually transmitted diseases (STDs), including AIDS, genital herpes, genital warts, syphilis, gonorrhea, and others. It provides details on causative agents, modes of transmission, clinical presentations, diagnosis, prevention, and treatment. STDs are a major public health issue due to their increasing worldwide incidence, high costs of treatment and complications, and their link to socioeconomic and behavioral factors.
This document summarizes treatment guidelines for COVID-19 based on disease severity and stage:
- Monoclonal antibodies like Sotrovimab and Bebtelovimab can reduce hospitalization when given early for mild-moderate cases. Antiviral pills Paxlovid and Molnupiravir may also be options.
- For hospitalized patients, remdesivir, corticosteroids like dexamethasone, and IL-6 inhibitors like tocilizumab are recommended. Baricitinib may also help reduce mortality. Remdesivir works best early in hospitalization while corticosteroids are preferred later for patients with ARDS.
- Guidelines discuss optimal dosing of cort
1. Determine when the pain started, how severe it is, and if it is getting worse over time. Severe abdominal pain that is worsening is a serious sign.
2. Check if the patient has constipation, diarrhea, vomiting, or a swollen, hard, and tender abdomen. These can indicate more serious underlying issues.
3. For new abdominal pain that is severe or worsening, the patient should be taken immediately to the hospital without eating or drinking. For recurring abdominal pain, further examination is needed to diagnose the cause. Some causes like intestinal worms can be treated in the community.
COVID-19 is a novel coronavirus that was declared a pandemic in March 2020. It has since infected over 2.5 million people globally with over 187,000 deaths. Common symptoms include fever, cough and shortness of breath. Diagnosis involves travel history screening, chest imaging and PCR testing of respiratory samples. Most cases are mild but some can progress to pneumonia or multi-organ failure. Treatment is supportive and there is no vaccine currently available, but over 100 candidates are in development.
This document provides an overview of tuberculosis (TB). It discusses that TB infects around 9 million people and causes 1.5 million deaths annually, making it a major global health problem. Key topics covered include the causative agent Mycobacterium tuberculosis; epidemiology of TB including increasing rates of drug-resistant and HIV-associated TB; risk factors; clinical presentation; diagnosis using smear microscopy, culture, radiography and other tests; treatment of drug-sensitive and drug-resistant TB; prevention through contact investigation and vaccination; and challenges to eliminating TB. The presentation emphasizes the continued burden of TB worldwide despite available diagnostic tools and treatments.
This document discusses COVID-19 in children. It provides details on SARS-CoV-2, including its infectivity, replication sites, and stability on surfaces. It also summarizes the pathophysiology of COVID-19 in children, noting their lower morbidity is likely due to factors like lower ACE2 expression. The diagnosis section outlines common manifestations in children and molecular testing methods, sample collection, hematologic parameters, and poor prognostic markers seen in adults.
Clinical and epidemiological features of Children with COVID 19Ramin Nazari M.D
- Children can be infected with COVID-19 but symptoms tend to be mild. Severe cases have occurred but are rare, especially in otherwise healthy children. Younger children, especially infants, may be more vulnerable to severe illness.
- A study in China found that 34% of COVID-19 cases in children were confirmed via lab tests while 66% were suspected cases. The majority of cases were mild. Severe or critical cases were more common in younger age groups, especially children under 1 year old.
- While children can spread the virus, severity of illness in children is generally milder than in adults. No significant differences in infection rates between boys and girls were observed.
The document discusses the 2009 H1N1 influenza pandemic. It provides details on the virus, symptoms, transmission, management and treatment recommendations, and control measures. As of December 2009, over 9,500 deaths had been reported worldwide from the H1N1 virus. While the overall global mortality rate was approximately 1%, continued virus transmission was observed across many regions. Vaccines and antiviral medications such as oseltamivir were the primary interventions recommended for treatment and prevention.
Rekha Dehariya (M.Sc nursing 1st year) Bhopal Nursing College, Bhopal
Covid -19 has effected broud number of people all over the world. the health education is necessary to aware people about it.
1. In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, China, causing a pneumonia outbreak of unknown origin.
2. The virus spread rapidly worldwide, and in March 2020 the WHO declared a global pandemic with over 118,000 cases across 114 countries.
3. Common symptoms of COVID-19, the disease caused by SARS-CoV-2, include fever, cough, and shortness of breath, with severe cases potentially resulting in acute respiratory distress.
Hepatitis A and typhoid fever are vaccine-preventable waterborne diseases transmitted through the fecal-oral route. They remain a major public health issue in Pakistan, with over two-thirds of the population lacking access to clean drinking water. Typhoid fever in particular is endemic in Pakistan, with high rates of multidrug-resistant Salmonella strains emerging. Vaccination is critical to control these diseases and reduce their significant health and economic burden.
The document profiles dengue infection in pregnancy at Sanglah Hospital in Bali, Indonesia. It finds that the highest percentage of infected women were in their third trimester (78%). Most women tested positive for dengue IgG antibodies (90.2%), indicating a secondary infection. Adverse outcomes for mothers included dengue-related death (14.6%) and preterm labor (17.1%). Few infants exhibited complications, with no neonatal deaths reported. The study provides insights into dengue infection patterns and effects during pregnancy in Bali.
Dengue Chikukunya & Malaria in the viewpoint of Medicine Paediatric & ObstetricsMuhammad Helmi
Multidisciplinary Seminar on Vector Borne Diseases such as dengue, malaria and chikungunya was discussed. It was introduced that vectors are living organisms that can transmit infectious diseases between humans or from animals to humans. There are two main types of vectors - biological and mechanical. Vector borne diseases account for over 17% of all infectious diseases and cause more than 1 billion cases and over 1 million deaths every year. Dengue, malaria and chikungunya were some of the key vector borne diseases highlighted. Their causative agents, transmission, clinical features and management were explored. Emphasis was placed on prevention and control of their vectors to curb the spread of these diseases.
Epidemiology of tb with recent advances acknowledged by whoRama shankar
This document provides an overview of tuberculosis epidemiology and recent advances in tuberculosis programs. It discusses the global and national burden of tuberculosis, the evolution of tuberculosis control programs in India including the National Tuberculosis Control Programme and Revised National Tuberculosis Control Programme. It covers diagnosis, treatment, drug-resistant tuberculosis, tuberculosis and HIV coinfection, and recent advances acknowledged by the WHO. The post-2015 tuberculosis strategy in relation to sustainable development goals is also mentioned.
Incorporate the visual brilliance of COVID 19 Template PowerPoint Presentation Slides to deliver a gripping presentation. Using the coronavirus PPT theme, you can display global epicenters of this pandemic on a world map diagram. With the help of this corona PowerPoint slideshow, you can spread awareness by communicating symptoms of the disease. Demonstrate the healthcare system capacity and the number of cases using the line graph given in the COVID 19 PPT template. The concise dashboard diagrams included in this 2019-nCoV disease PowerPoint presentation are appropriate to showcase key statistics of the pandemic. Novel coronavirus pneumonia PPT slideshow helps you to highlight the major pandemics of the modern era like the 1700s smallpox outbreak. Elucidate country-wise stats related to the disease using the dashboard layout in this severe pneumonia with novel pathogens PowerPoint theme. So, download this COVID-19 PPT presentation to outline the affected areas, precautionary measures, and other fundamentals. https://bit.ly/3gGPcTC
This document summarizes information from Dr. Tahseen J. Siddiqui on COVID-19. It discusses the three known coronaviruses that cause SARS, MERS, and COVID-19. It emphasizes that mitigation through strict social isolation is the best current strategy to slow transmission rates and prevent healthcare systems from being overwhelmed. The risks of personal infection are low but systemic risks are high if many require critical care simultaneously. Early action through testing, contact tracing, and quarantines have helped countries like Taiwan better control the spread.
Covid 19 aka mers cov2 update and perinatal covidSri ChowdarRy
This document provides an overview of COVID-19 (coronavirus disease 2019), caused by the novel coronavirus SARS-CoV-2. It discusses the virology, epidemiology, clinical features, course, complications, diagnosis, and prevention of COVID-19. Key points include that SARS-CoV-2 is a betacoronavirus that uses the ACE2 receptor for cell entry, most infections are mild but some can be severe or critical, common symptoms include fever and cough but some patients are asymptomatic, and chest CT often shows bilateral ground-glass opacities consistent with viral pneumonia.
This document provides guidance on evaluating and managing acute febrile illness in returning travelers. It outlines:
1) Common causes of fever in returning travelers, including malaria, dengue, influenza, and enteric fever.
2) Recommendations for obtaining a thorough travel history, physical exam, and diagnostic testing based on the patient's symptoms, risk factors, and travel destinations.
3) Treatment guidelines for various infections based on disease severity and suspected pathogen.
This document provides information on updated disease notification responsibilities and immunization guidelines. It lists diseases that medical facilities must notify responders about after exposure. These include bloodborne, airborne, and droplet transmitted diseases like hepatitis, HIV, influenza, meningitis and more. The document discusses prevention of diseases through travel screening, herd immunity from vaccination, and recent disease case numbers. It provides guidance on healthcare worker vaccination and testing requirements.
This document provides an overview of emerging and re-emerging infectious diseases as well as potential agents of bioterrorism that could be encountered in an emergency department setting. It discusses several specific diseases including SARS, West Nile virus, influenza, anthrax, smallpox, and plague. For each disease, it summarizes the causative agent, transmission, signs and symptoms, diagnosis, and treatment. The overall goal is to introduce emergency physicians to these threats and how to recognize and respond to cases of emerging infection or potential bioterrorism.
Dengue is a mosquito-borne viral disease that is widespread in tropical and subtropical regions. It affects nearly 100 million people annually. The disease is caused by the dengue virus, which has four serotypes. It is transmitted by the bite of infected Aedes mosquitoes. There is no vaccine available to prevent dengue. Treatment involves fluid replacement and pain management. Prevention focuses on reducing mosquito habitats and biting through the use of insect repellents, bed nets, and larviciding.
This document discusses sexually transmitted diseases (STDs), including AIDS, genital herpes, genital warts, syphilis, gonorrhea, and others. It provides details on causative agents, modes of transmission, clinical presentations, diagnosis, prevention, and treatment. STDs are a major public health issue due to their increasing worldwide incidence, high costs of treatment and complications, and their link to socioeconomic and behavioral factors.
This document summarizes treatment guidelines for COVID-19 based on disease severity and stage:
- Monoclonal antibodies like Sotrovimab and Bebtelovimab can reduce hospitalization when given early for mild-moderate cases. Antiviral pills Paxlovid and Molnupiravir may also be options.
- For hospitalized patients, remdesivir, corticosteroids like dexamethasone, and IL-6 inhibitors like tocilizumab are recommended. Baricitinib may also help reduce mortality. Remdesivir works best early in hospitalization while corticosteroids are preferred later for patients with ARDS.
- Guidelines discuss optimal dosing of cort
1. Determine when the pain started, how severe it is, and if it is getting worse over time. Severe abdominal pain that is worsening is a serious sign.
2. Check if the patient has constipation, diarrhea, vomiting, or a swollen, hard, and tender abdomen. These can indicate more serious underlying issues.
3. For new abdominal pain that is severe or worsening, the patient should be taken immediately to the hospital without eating or drinking. For recurring abdominal pain, further examination is needed to diagnose the cause. Some causes like intestinal worms can be treated in the community.
COVID-19 is a novel coronavirus that was declared a pandemic in March 2020. It has since infected over 2.5 million people globally with over 187,000 deaths. Common symptoms include fever, cough and shortness of breath. Diagnosis involves travel history screening, chest imaging and PCR testing of respiratory samples. Most cases are mild but some can progress to pneumonia or multi-organ failure. Treatment is supportive and there is no vaccine currently available, but over 100 candidates are in development.
www.slideshare.ne www.slideshare.ne Tuberculosis (TB) is fatal
contagious disease that affects the lungs and other part of body which is a public health problem but curable and preventable disease .
Caused organism : bacteria (Mycobacterium tuberculosis
Human : Mycobacterium tuberculosis
Pulmonary TB
Extra pulmonary TB
Animals : Mycobacterium Bovis
Bovine tuberculosis (TB) is a chronic disease of animals caused by a bacteria called Mycobacterium bovis, (M.bovis) which is closely related to the bacteria that cause human
Covid19 and pregnancy: There are case reports of preterm birth in women with COVID-19 but it is unclear whether the preterm birth was always iatrogenic, or whether some were spontaneous.
Pregnancy and COVID-19:
- Pregnancy does not increase the risk of contracting COVID-19 but can cause more severe symptoms due to an altered immune system.
- Most cases in pregnant women are mild, but a small portion can experience severe disease requiring intensive care.
- Vertical transmission from mother to fetus/newborn appears rare based on limited data, though a few possible cases have been reported.
- Routine antenatal care should focus on telehealth and limiting in-person visits when possible to reduce infection risk. Testing criteria include symptoms or exposure risk.
- Management of COVID-19 in pregnancy focuses on supportive care, with delivery timing based on gestational age and maternal condition.
This document provides information about tuberculosis (TB), including its introduction, epidemiology, definition, modes of transmission, clinical presentation, treatment, prevention, and management. Some key points include:
- TB is caused by the bacterium Mycobacterium tuberculosis and can spread through the air from one person to another. It affects millions of people worldwide each year.
- Symptoms may include cough, fatigue, weight loss, fever, and breathing difficulties. Diagnosis involves tests like the Mantoux skin test, chest x-ray, and sputum microscopy.
- Treatment involves standardized short course chemotherapy over 6-8 months using combinations of front-line antibiotic drugs. Prevention strategies focus on BCG vaccination, screening of contacts
National TB Elimination Programme in India aims to eliminate TB by 2025. TB remains a major public health problem in India, being one of the leading causes of death. In 2019, the estimated TB incidence was 26.4 lakh cases and estimated deaths were 4.45 lakh. There is a large gap between estimated cases and cases notified to the government. Private sector notification is very low. The government's targets are to reduce TB deaths by 90% and cut incidence rate by 80% by 2025 compared to 2015. This will require detecting all TB cases, ensuring treatment completion, preventive measures like contact screening, and building strong public-private partnerships.
The document provides information and guidance for reporting notifiable diseases from the emergency department setting. It lists diseases that should be reported including new and emerging infections, outbreaks, and infections that put vulnerable groups at risk. The document also discusses the criteria for pyrexia of unknown origin, malaria, and managing animal and human bites. It provides the rabies risk assessment form and outlines tetanus immunization guidance and HIV exposure management.
- The document discusses whether people should get the H1N1 vaccine. It provides historical context on influenza pandemics and vaccines. It addresses common myths about flu vaccines and H1N1 specifically, noting that vaccines are safe, effective, and have an excellent safety record. The costs of vaccination are far lower than the societal costs of influenza epidemics.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while the JNC 8 guidelines from 2013 include treatment algorithms and comparisons to JNC 7.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while JNC 8 included treatment algorithms and differences from JNC 7.
This document provides an overview of the 2019 novel coronavirus (2019-nCoV) outbreak that began in Wuhan, China in December 2019. It describes the clinical presentation and management of 2019-nCoV, compares it to other coronaviruses like SARS and MERS, and outlines current WHO guidance on case definitions, investigations and infection control.
This document provides information about tuberculosis (TB) in the Philippines. It states that TB is considered the world's deadliest disease and remains a major public health problem in the Philippines. It is caused by tubercle bacilli and primarily affects the respiratory system but can also affect other organs. It ranks as the 6th leading cause of morbidity and mortality in the Philippines. The document then provides details on symptoms, transmission, diagnosis and treatment of TB cases according to national policies and guidelines. It also discusses the DOTS strategy for TB control.
This document discusses communicable diseases that commonly affect the elderly population. It summarizes that geriatrics refers to healthcare for elderly people, noting that the elderly population is growing rapidly. Some common communicable diseases that impact the elderly include pneumonia, influenza, herpes zoster, urinary tract infections, and gastrointestinal infections such as H. pylori and C. difficile infections. Prevention strategies include vaccination, hygiene practices, and early treatment of infections to prevent worsening and spread.
This document provides guidance for healthcare professionals on coronavirus (COVID-19) infection in pregnancy. It includes:
1. General advice on COVID-19 transmission, epidemiology, and effects on pregnant women and fetuses.
2. Advice for health professionals to share with pregnant women, including on social distancing, self-isolation, and attending appointments.
3. Advice for midwifery and obstetric services on continuing antenatal and postnatal care during the pandemic, including use of telehealth and protocols for women in self-isolation.
The document discusses the deadly combination of the HIV/AIDS and tuberculosis (TB) pandemics. It states that around 12 million people worldwide are co-infected with HIV and TB, and that each disease makes the other worse. New tools are needed to combat the co-epidemic, including vaccines, diagnostics, and treatments. The Aeras Global TB Vaccine Foundation is working to develop new TB vaccines to help eliminate TB globally by 2050.
1. Implement a patient intake form to routinely assess vaccination status at every visit and identify which vaccines are needed.
2. Use standing orders and protocols to allow nurses and other staff to administer recommended vaccines.
3. Refer patients to pharmacies or health departments for vaccines not stocked in the practice and document referrals.
3. Enter administered vaccines and referrals into the state immunization registry to track rates and prevent missed opportunities.
This document provides an overview of COVID-19 including its timeline, transmission, presentation, epidemiology, prevention, and containment plan. It discusses that COVID-19 is a respiratory infection caused by SARS-CoV-2. It outlines the timeline of the outbreak beginning in December 2019 in Wuhan, China. It also discusses transmission modes, signs and symptoms, disease progression, prevention strategies like isolation, quarantine, hand hygiene, and use of personal protective equipment.
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
How to Add Chatter in the odoo 17 ERP ModuleCeline George
In Odoo, the chatter is like a chat tool that helps you work together on records. You can leave notes and track things, making it easier to talk with your team and partners. Inside chatter, all communication history, activity, and changes will be displayed.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
A review of the growth of the Israel Genealogy Research Association Database Collection for the last 12 months. Our collection is now passed the 3 million mark and still growing. See which archives have contributed the most. See the different types of records we have, and which years have had records added. You can also see what we have for the future.
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
2. 2
What Are We Going To Do ...
Talk about any changes in BBP info during the last 12
months
Look at local infectious disease numbers
A quick review on basic disease information
Review information specific to Loudoun County
3. 3
National Disease Numbers
2010
AIDS – 36,870
Hepatitis B – 3,405
Hepatitis C – 782
Syphilis – 44,828
TB – 11,182
WNV- 524
Lyme – 22,561
5. 5
Virginia Numbers
2011
AIDS 1108
HIV 577
TB 221
Syphilis 717
Hepatitis B 667
West Nile Virus 9
Lyme Disease 1023
2012 (as of 9/1/12)
AIDS 415
HIV 769
TB 112
Syphilis 489
Hepatitis B 351
West Nile Virus 9
Lyme Disease 454
6. 6
Loudoun Numbers
2011
AIDS 13
HIV 23
TB 12
Syphilis 4
Hepatitis B 64
West Nile Virus 0
Lyme Disease 261
2012 (as of 9/1/12)
AIDS 9
HIV 18
TB 7
Syphilis 9
Hepatitis B 46
West Nile Virus 0
Lyme Disease 125
12. 12
Body Fluids That Pose A Risk
Primary Risk
Blood
Semen
Vaginal Secretions
Secondary Risk
Synovial Fluid
Pericardial Fluid
Pleural Fluid
Amniotic Fluid
Cerebrospinal Fluid
Any other body fluid
containing visible
blood
“O.P.I.M.”
13. 13
Tears, sweat, urine, stool,
vomitus, nasal secretions,
and sputum do not pose
a risk unless they contain
visible blood!
14. Human Bites & Exposure
If a patient bites you
and draws blood…
You have not had an
exposure. The patient
has had the exposure,
to your blood!
14
15. 15
What constitutes an
exposure?
NOT AN EXPOSURE
Blood on intact skin
Vomit on your face
Urine on your skin
Patient coughs in the
ambulance.
AN EXPOSURE
Blood on broken skin
Vomit (with visible blood
in it) in your eyes
Blood coughed in eyes
and/or mouth while
suctioning
18. 2009 lowest case number since 1953
11,540 cases
Largest 1 year decrease since 1993
Five states carry over 52% of the total number of cases:
Florida, Texas, New York, California, Illinois
Tuberculosis
18
19. 19
TB Testing
The Tuberculin Skin Test
(used to be called the
PPD) is no longer used
by LCFR for annual
testing of career staff.
20. 20
TB Blood Test Guidelines
QuantiFERON (QFT-Gold)
Blood test for latent TB infection
Used for screening healthcare
workers/military personnel/correctional staff
No need to return for readings
Can be used with personnel who had previous
positive TST tests
21. 21
Tuberculosis
If you are transporting a patient who is actively
coughing and is high risk for TB:
Place a mask on the patient – an NRB is
adequate.
Would it be effective to place an N-95 on the
patient?
23. 23
MRSA
Methicillin-resistant staphaureus (MRSA)
Most associated with healthcare settings. CDC report from 2010
shows that there has been a significant decline in MRSA since
2005.
Most frequent among people with weakened immune systems, the
elderly, children.
31. 31
Hepatitis B (HBV)
Virus that attacks the liver
Very virulent
Direct or indirect contact
“Window” = 45 days “Incubation” = up to 6 months
Early Findings = flu-like illness (communicable)
Late Findings = yellow skin/eyes, dark urine, liver
enlargement (non-communicable)
No cure...vaccine (Recombivax) is available
32. 32
Hepatitis B Vaccine
Reminder
Offers protection via “immunologic memory”
There is NO formal requirement or recommendation
for a booster
Titer 1-2 months after completion of vaccine series
is required- OSHA enforcing
CDC, 1992,1997, June 29, 2001
34. 34
Hepatitis C Cases
The acute incidence continues to decline
Additional data shows an increased risk with
tattoos and body piercing.
Rate in US – 1.3%
3.2 million people in U.S. have chronic HCV
infection
35. 35
Hepatitis C- Transmission
Blood
IV drug use
Mother to infant
Intranasal cocaine use
Sexual Contact
Multiple partners
High-risk sexual practices
36. 36
Hepatitis C - HCW Infection
There is no recommendation for the routine
screening of healthcare workers
Hepatitis C is not efficiently transmitted
occupationally
• AJIC, 1999, Vol.. 27 (1):54-55
• CDC, 1998, CDC, 6/29/01
38. 38
Human Immunodeficiency
Virus (HIV)
Virus that attacks the immune system
Low virulence
“Window” = 1-12 weeks...”Incubation” = up to 10 years
Early Findings = none to mild flu-like symptoms
Late Findings = varied, depending on infections
produced by ineffective immune system
No cure...No vaccine
39. 1978 – December, 2006
57* documented cases
0 in fire/EMS personnel
49 were sharps related exposures
No new reported cases since 2000
Occupational Infection-HIV
CDC, 2008(CDC), NIOSH
39
40. Rapid HIV Tests
Rapid HIV Testing currently available
OraQuick
Reveal
Uni-Gold
Multispot
Clearview
40
41. If source patient is negative with rapid testing = no
further testing of health-care worker
Use of rapid testing will prevent staff from being
placed on toxic drugs for even a short period of
time
Testing Issues - Post
Exposure
•CDC, May , 1998, CDC June 29, 2001, September 2005
41
43. 43
Influenza (Flu)
Airborne virus transmitted by droplet contact
Respiratory tract infection caused by the influenza virus.
Fever, cough, sore throat, runny nose, muscle aches,
extreme fatigue are common. (Clear in 1 to 2 weeks)
20,000 deaths nationwide and more than 100,000
hospitalizations, annually.
The elderly and people with chronic health problems are
much more likely to be seriously affected
45. CDC Flu Vaccine Program
Employers must offer
Employers must pay
Employees who
decline - sign a
declination form
CDC, February 24, 2006/2008/2009, NFPA 1581
45
46. FluMist – Nasal Spray
For healthy persons
2- 49 years old
Does not need to be
stored frozen
Do not take if pregnant
– live virus vaccine
No thimerosal
Is egg based
Cost reduced
No work restriction
46
47. „Swine‟ flu is not expected to be a big component of this
year‟s flu season.
If you had the H1N1 vaccine, it is still protective. No
booster is necessary.
H1N1 Flu Virus
47
49. Adult
Shortness of breath
Chest pain/pressure
Dizziness
Confusion
Persistent vomiting
Pediatric
Respiratory distress
Bluish skin color
Irritability
Fever with rash
Low fluid intake
Not waking or
interacting
Severe Signs/Symptoms
49
50. Place a surgical mask on patient
If that isn‟t possible, place a surgical mask
on yourself
Good handwashing
Use good airflow in vehicle
If a patient is suspected of
having the flu
50
51. Flu virus survives on hard surfaces for
about 2 hours
Routine cleaning is important
Equipment
Surfaces in vehicle
Survival on Surfaces
51
59. CDC Statement
Health-care personnel place themselves and their patients
at risk if they are not protected against measles.
In accordance with current recommendations, health-care personnel
should have documented evidence of measles immunity¶¶ readily
available at their work location (3).
If this documentation is not available when measles is introduced,
major costs and disruptions to health-care operations
can result from the need to exclude potentially infected
staff members and rapidly ensure immunity for others (6).
CDC, May 1, 2008
60. 60
Mumps
In order to be considered immune:
History of physician diagnosis OR
Receipt of at least 1 dose of mumps vaccine
OR
Positive mumps IgG
61. 61
Mumps Vaccine - Update
2 doses needed for coverage
1 dose = 80% protection
Vaccine cannot be used post-exposure
CDC, 2006
63. Measles – Virginia 2008
8 EMS personnel exposed
No documentation of immunity available
Personnel needed an average of 36
hours off duty for testing
Cost- $14,400.00
66. 66
The Prevention Program
Includes…
Education on Infection Control
Encouraging good hygiene practices
Eat a healthy diet
Proper cleaning & disinfection of athletic equipment
Proper handling of blood and OPIM
67. 67
By altering one component of the triangle, one or
more of the other components may be changed
Environment – Surfaces, Equipment, Personnel who come to work with
infections
Causal Agent - Herpes, HOST: Recruits,
Staph Infections EMTs,
MRSA Firefighters, Officers
68. 68
Host
(Personnel)
Healthy Habits
Diet rich in green, yellow, and orange
vegetables can bolster natural immunity.
Drinking 8 to 10 glasses of water a day
can help flush disease causing organisms
from the body.
Regular exercise.
69. 69
Alter the Environment
Hygiene Practices
Keep cuts & scrapes clean and covered
Do not share personal items
Towels, soap, razors, tweezers, sports equipment, ball caps, linen
etc.
Shower after PT or strenuous activities
Hand Hygiene
Wash your hands
Soap and water is best
Waterless hand sanitizer if soap & water is not available
Antibacterial soap is not recommended
70. 70
Cleaning of equipment
All Chemical Germicides and Bleach Solutions (1
part bleach to 100 parts water)
MIX Appropriately
USE Appropriately
READ and FOLLOW LABELS
71. 71
Infection Control
BSI – aka Standard Precautions
Good handwashing
NRB or Surgical mask on the patient
Protective eyewear
N-95 respirator for care provider
72. 72
Prevention for HCW’s
Handwashing -
After touching blood/body fluids/contaminated
objects
After glove removal
Provide 15 sec. of friction
DO NOT squeeze the site to express blood
73. 73
Hand Hygiene Guidelines
No antibacterial soap
Alcohol based foam
or gel
No artificial nails or
extensions
• CDC, October,2002
74. 74
Glove Use - Reminder
Practical and feasible-
Gloves must be used when there is reasonable
anticipation of contact with contaminated surfaces or
when performing vascular access procedures, direct
contact with patient mucous membranes or non-
intact skin
75. 75
Prevention for HCW’s
Mask Use - Eye
Protection
For procedures that
may generate
splash/splatter of
blood/body fluids
76. 76
Mask Clarification
Surgical mask
Filters what goes out
Respirator
Filters what comes in
Never put a
respirator on a
patient
78. 78
Loudoun County
Infection Control Officers
Designated Infection Control Officer –
Deputy Chief Jose Salazar
Back up Infection Control Officers –
Battalion Chief Tim Menzenwerth
Captain James Cooper
Captain Micah Kiger
Captain Mike Mahoney
Captain Daniel Neal
80. 80
When an exposure happens!
Don‟t Panic…did you really get exposed?
Clean the site with soap and water as soon as
possible.
Immediately call LCFR – ECC and have the
Infection Control Officer notified
Notify the receiving health care facility of the
exposure.
Do not provide your personal insurance information
81. 81
When an exposure happens!
The ICO will discuss your report with you and provide
you with additional instructions.
Follow-up procedures may be required.
All information pertaining to your exposure incident will
be keep confidential.
82. 82
When an Exposure Occurs
If the source patient is identified and tested, there is no
need to draw bloods on employee.
If source patient tests are positive, then follow up will be
done.
83. 83
Loudoun County, Virginia
www.loudoun.gov
Management and Financial Services, Human Resources / Benefits
1 Harrison St., SE, 4th
Floor, MS #41A Leesburg, VA 20177-7000
Telephone (703) 777-0517 Fax (571) 258-3212
Employee’s Report of Injury (Must Be Handwritten)
Instructions-Employee: Please complete this report and return to your supervisor. Supervisor: Review incident with employee and then ente r the
required information onto the Employer’s Accident Report. Send both original injury reports to the Workers’ Comp dept. within 48 hours.
Name (First, Middle, Last) _______________________________________________________________________
Address__________________________________ City_________________________ State______ Zip_________
Phone No. ____________________ Date of Birth _________________ Social Security No. ___________________
Job Title _____________________ Department _____________________________________________________
Injury Date ___________________ Time of Injury __________ Overtime Yes/No Last Day Worked___________
Date Supervisor Notified___________________ Date Returned to Work __________________________________
What was the injury or illness?
State exact part of the body affected and what the injury or illness was.
Injury________________________________________________________________________________________
Body Part______________________ Specific Area_______________________ Please Circle: Left Right N/A
What were you doing just before the incident occurred?
Describe the activity, as well as the tools, equipment or material you were using. Be Specific. Example: “Arresting subject .”
____________________________________________________________________________________________
____________________________________________________________________________________________
How did the injury/illness occur?
Example: “While arresting subject, fell to the ground and landed on arm.”
____________________________________________________________________________________________
____________________________________________________________________________________________
Where did the incident happen? __________________________________________________
What can be done to prevent future occurrence?
____________________________________________________________________________________________
Where did you go for medical treatment? ______________________________________N/A
I certify that the information in this Work-Related Injury Report is true and accurate to the best of my knowledge. I understand that the County
will rely upon this form in evaluating my claim. I further understand that this document may be presented or used in support of or against a claim
for payment under the County’s policy of workers’ compensation insurance. I understand falsification of any information on or about this injury
report form or the alleged injury, and the assertion of a false workers’ compensation claim, are violations of Virginia’s Criminal laws, may result
in a fine and imprisonment and/or termination of my employment.
Employee Signature___________________________________________________ Date _____________________
Supervisor Signature___________________________________________________Date_____________________
Employee’s
report of injury
84. 84
Employer’s Accident Report
(formerly: Employer’s First Report of Accident) The boxes
Reason for filing VWC file number
Virginia Workers’ Compensation Commission
1000 DMV Drive Richmond, VA 23220
to the right
are for the
Insurer code or PEO Ref. No.
90267
Insurer location
760
See instructions on the reverse of this form use of the
insurer
Insurer claim number
Employer
1. Name of employer (trading as or doing business as, if applicable)
County of Loudoun, VA
2. Federal Tax Identification Number
54-0948306
3. Employer’s Case No. (if applicable)
4. Mailing address
P.O. Box 7000, 1 Harrison Street., SE
Leesburg, Virginia 20177
5. Location (if different from mailing address)
6. Parent corporation /Policy Named Insured (if applicable) or PEO name
Loudoun County Government
7. Nature of business
County Government/Volunteer Fire & Rescue
8. Name and Address of Insurer or self-insurer for this claim
Wells Fargo Disability Management
9. Policy number 10. Effective date
Time and Place of Accident
11. City or county where accident occurred
Loudoun County
12. Date of injury 13. Hour of injury
a.m. p.m.
14. Date of incapacity 15. Hour of incapacity
13a. Time began work
a.m. p. m.
16. Was employee paid in full of day of injury?
Yes No
17. Was employee paid in full for day incapacity began?
Yes No
18. Date injury or illness reported 19. Person to whom reported 20. Name of other witness 21. If fatal, give date of death
Employee
22. Name of employee (Last, First, Middle) 23. Phone Number 24. Sex
Male Female
25. Address 26. Date of Birth 27. Marital Status
Single Divorced
28. Social Security Number
Married Widowed
29. Occupation at time of injury or illness (SOC code, if applicable) 30. Is worker covered by PEO policy?
Yes No
31. Number of dependent
children
32. How long in current job? 33. Date of Hire 34. Was employee paid on a piece work
or hourly basis? Piece work Hourly
35. Hours worked
per day
36. Days worked
per week
37. Value of perquisites per week
Food/Meals Lodging Tips Other
38. Wages per hour
$
39. Earnings per week (inc. overtime)
$ $ $ $ $
Nature and Cause of Accident
40. Machine, tool, or object causing injury or illness 41. Specify part of machine, etc.
42. Describe fully how injury or illness occurred
43. Describe nature of injury or illness, including arts of body affected 43a. Overnight inpatient hospitalization?
Yes No
43b. Treated in Emergency Room? Yes No
44. Physician (name and address) 45. Hospital (name and address)
46. Probable length of disability 47. Has employee returned
to work? Yes No
If
Yes
48. At what wage? 49. On what date?
50. EMPLOYER: prepared by (name, signature, title) 51. Date 52. Phone Number
53. INSURER: (name of processor) 54. Date 55. Phone number
56. THIRD PARTY ADMINISTRATOR (if applicable) 57. Address 58. Phone number
This report is required by the Virginia Workers’ Compensation Act Employer’s Accident Report
VWC Form No. 3 (rev. 03/22/02)
Employer’s
Accident report
to be filled out
by supervisor
85. 85
Loudoun County, Virginia
www.loudoun.gov
Management and Financial Services, Human Resources / Benefits
1 Harrison St., SE, 4th
Floor, MS #41A Leesburg, VA 20177-7000
Telephone (703) 777-0517 Fax (571) 258-3212
Volunteer’s Report of Injury (Handwritten)
Instructions-Volunteers: Please complete this report and return to your supervisor. Supervisor: Review incident with employee and then enter the
required information onto the Employer’s Accident Report. Send both original injury reports to OHS@loudoun.gov within 48 hours.
Name (First, Middle, Last)
_______________________________________________________________________
Address__________________________________ City_________________________ State______ Zip_________
Phone No. ____________________ Date of Birth _________________ Social Security No.
___________________
Job Title _____________________ Department _____________________________________________________
Injury Date ___________________ Time of Injury __________
Date Supervisor Notified___________________ Date Returned to Work __________________________________
What was the injury or illness?
State exact part of the body affected and what the injury or illness was.
Injury________________________________________________________________________________________
Body Part______________________ Specific Area_______________________ Please Circle: Left Right N/A
What were you doing just before the incident occurred?
Describe the activity, as well as the tools, equipment or material you were using. Be Specific. Example: “Arresting subject.”
____________________________________________________________________________________________
____________________________________________________________________________________________
How did the injury/illness occur?
Example: “While arresting subject, fell to the ground and landed on arm.”
____________________________________________________________________________________________
____________________________________________________________________________________________
Where did the incident happen?
__________________________________________________
What can be done to prevent future occurrence?
____________________________________________________________________________________________
Where did you go for medical treatment? ______________________________________N/A
I certify that the information in this Work-Related Injury Report is true and accurate to the best of my knowledge. I understand that the County will
rely upon this form in evaluating my claim. I further understand that this document may be presented or used in support of or against a claim for
payment under the County’s policy of workers’ compensation insurance. I understand falsification of any information on or about this injury report
form or the alleged injury, and the assertion of a false workers’ compensation claim, are violations of Virginia’s Criminal laws, may result in a fine
and imprisonment and/or termination of my employment.
Volunteer’s Signature_________________________________________________ Date _____________________
Supervisor Signature__________________________________________________Date_____________________
Volunteer
Report of
Injury
86. 86
Good Samaritan Exposure
Complete the “Good Samaritan Handout” at scene.
If unable to locate form, provide the Infection Control
Officer the following:
Good Samaritan’s name
Contact information
Unit # the patient was transported by
Incident # and Patient #
Name of facility patient was transported to
87. 87
GOOD SAMARITAN EXPOSURE FORM
If you have received a person’s blood or body fluid into your eye, mouth, nose, or other mucous
membrane, non-intact (an open area of your skin), or an object containing blood or body fluids
pierced your skin, then you have receive an exposure..
The Virginia law on deemed consent states that if you have received an exposure (as defined
above) to a person’s blood or other potentially infectious materials while rendering emergency
assistance, you are entitled to have the person tested for HIV, Hepatitis B, and Hepatitis C and to
receive the results of those tests.
Call the Loudoun County Emergency Communication Center at (703) 777-0637 immediately,
and advise them that you have received an exposure and are requesting the Designated Infection
Control Officer to assist you. Please provider your name and the phone number where you can
be reached at that time.
The Designated Infection Control Officer will need the following information (Obtain from the
fire-rescue member on the emergency scene):
Date and Time of event: ___________________
Agency and Unit # the patient was transported by: _________
Incident # ______________
Patient # (if more than one) _______
Name of the medical facility the source patient was transported to:
_____________________________________
.
Masking the patient is the most direct protection as secretions are contained at the source. A surgical mask will offer you protection as well
Survival time on surfaces is approximately 2 hours. The importance of cleaning between patient transports is important. This is especially important as transmission via stool has not been ruled out.